Skip to main content

JS Ross

First name:
JS
Last name:
Ross
Ross, J. ., Fakih, M. ., Ali, S. ., Elvin, J. ., Schrock, A. ., Suh, J. ., … Gay, L. . (2018). Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. https://doi.org/10.1002/cncr.31125 (Original work published 2018)
Egilman, A. ., Wallach, J. ., Ross, J. ., & Dhruva, S. . (2018). Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2017.8016 (Original work published 2018)
Charalel, R. ., Durack, J. ., Mao, J. ., Ross, J. ., Meltzer, A. ., & Sedrakyan, A. . (2018). Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals: Epidemiology and Recent Trends. Medical Care. https://doi.org/10.1097/MLR.0000000000000867 (Original work published 2018)
Schrock, A. ., Pavlick, D. ., Klempner, S. ., Chung, J. ., Forcier, B. ., … Welsh, A. . (2018). Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-17-3103 (Original work published 2018)
Lin, J. ., Zhu, V. ., Yoda, S. ., Yeap, B. ., Schrock, A. ., Dagogo-Jack, I. ., … Ou, S. . (2018). Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017762294. https://doi.org/10.1200/JCO.2017.76.2294 (Original work published 2018)
Ross, J. ., & Krumholz, H. . (2018). Bringing Vioxx back to market. BMJ (Clinical Research ed.), 360, k242. (Original work published 2018)